
Nov 19-23 : Society of NeuroOncology Conference | Honolulu
Society for NeuroOncology 30th Annual Meeting & Education Day Event: 30th Society for Neuro-Oncology Annual Meeting & Education Day Dates: Nov 19-23, 2025 Location: Honolulu Nanology leade ...

Sept 25-28 : AACR Special Conference – Pediatric Cancer |. Boston
American Association for Cancer Research Special Conference in Cancer Research: Discovery and Innovation in Pediatric Cancer Event: Discovery & Innovation in Pediatric Cancer - from Biology to B ...

Sept 16-17 : BioNTX iC3 Life Science & Healthcare Innovation Summit- Dallas
BioNTX iC3 Life Science & Healthcare Innovation Summit | Dallas Event: BioNTX iC3 Life Science & Healthcare Innovation Summit Dates: Sept 16-17, 2025 Location: Hilton Anatole, Dallas Nano ...

JDDG: Cutaneous metastases: From epidemiology to therapy
Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 1 ...

NanOlogy Publishes Research Articles on the Immunomodulatory Effects of its Large Surface Area Microparticle Investigational Drugs
NanOlogy Publishes Research Articles on the Immunomodulatory Effects of its Large Surface Area Microparticle Investigational Drugs FORT WORTH (February 14, 2024) — NanOlogy LLC, a clinical-st ...

NanOlogy Clinical and Preclinical Immune Data Presented at NACLC and SITC
NanOlogy Clinical and Preclinical Immune Data Presented at NACLC and SITC Interim response and peripheral immunomodulation data from its Phase 2 clinical trial of IT LSAM-PTX in stage 3/4 lung ca ...

NanOlogy Announces an Abstract Has Been Accepted for Presentation at the IASLC North America Conference on Lung Cancer
NanOlogy Announces an Abstract Has Been Accepted for Presentation at the IASLC North America Conference on Lung Cancer FORT WORTH (November 20, 2023) — NanOlogy LLC, a clinical-stage oncology ...

NanOlogy Announces an Abstract Has Been Accepted for Presentation at the 38th SITC Annual Meeting
NanOlogy Announces an Abstract Has Been Accepted for Presentation at the 38th SITC Annual Meeting FORT WORTH (October 23, 2023) — NanOlogy LLC, a clinical-stage oncology company, announced to ...

Interim Results from a NanOlogy Phase 2 Clinical Trial of its Intratumoral Investigational Drug in the Treatment of Locally Advanced Pancreatic Cancer
Interim Results from a NanOlogy Phase 2 Clinical Trial of its Intratumoral Investigational Drug in the Treatment of Locally Advanced Pancreatic Cancer Research article published in Pancreas ...

NanOlogy Announces Two Abstracts Have Been Accepted for Presentation at AACR Special Conference in Cancer Research: Pancreatic Cancer
NanOlogy Announces Two Abstracts Have Been Accepted for Presentation at AACR Special Conference in Cancer Research: Pancreatic Cancer FORT WORTH (September 12, 2023) — NanOlogy LLC, a clinica ...